March 20, 2018

WorkCompRecap: Re-Listings & Rates!

Today’s issue of WorkCompRecap features some interesting drug formulary news with the TDI-DWC’s announcement that it is notifying system participants that the Work Loss Data Institute, publisher of the ODG, will make changes affecting two drugs listed in its workers’ comp drug formulary.

Effective February 1, 2016, Fentanyl transdermal patches and MS-Contin will move to “N” status, and will therefore require preauthorization approval. The DWC is preparing outreach efforts and is encouraging participants to begin discussing any ongoing courses of treatment if those drugs are being used.

Find out more by clicking here!

  • RSS
  • Twitter
  • LinkedIn